Skip to main content
Premium Trial:

Request an Annual Quote

Genedata Integrates its Analyst Software with TranSMART Platform


NEW YORK (GenomeWeb) – Genedata said this week that it has integrated its Genedata Analyst software with the TranSMART platform, an open-source knowledge-management platform managed by the TranSMART Foundation that lets users integrate phenotype data and molecular information in translational research and personalized medicine projects.

The combined product provides a single platform for analyzing and sharing omics and clinical data that reduces the amount of time required to import, export, integrate, and format data for processing; removes error-prone manual steps; and more, the company said. Genedata will showcase the solution at the Bio-IT World Conference next week in Boston.

The TranSMART platform is also integrated with the GenoSpace system, which offers cloud power and software to help researchers and clinicians analyze, share, and store both clinical and genomic information; and with the BT for Life Sciences cloud infrastructure, a service that telecommunications company BT launched last year to support scientists from pharmaceutical, biotechnology, devices, and diagnostics companies, as well as those in academia and government

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.